These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9669275)

  • 1. Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiograms.
    Grayburn PA; Weiss JL; Hack TC; Klodas E; Raichlen JS; Vannan MA; Klein AL; Kitzman DW; Chrysant SG; Cohen JL; Abrahamson D; Foster E; Perez JE; Aurigemma GP; Panza JA; Picard MH; Byrd BF; Segar DS; Jacobson SA; Sahn DJ; DeMaria AN
    J Am Coll Cardiol; 1998 Jul; 32(1):230-6. PubMed ID: 9669275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent. Results of a phase III Multicenter Trial.
    Cohen JL; Cheirif J; Segar DS; Gillam LD; Gottdiener JS; Hausnerova E; Bruns DE
    J Am Coll Cardiol; 1998 Sep; 32(3):746-52. PubMed ID: 9741522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opacification and border delineation improvement in patients with suboptimal endocardial border definition in routine echocardiography: results of the Phase III Albunex Multicenter Trial.
    Crouse LJ; Cheirif J; Hanly DE; Kisslo JA; Labovitz AJ; Raichlen JS; Schutz RW; Shah PM; Smith MD
    J Am Coll Cardiol; 1993 Nov; 22(5):1494-500. PubMed ID: 8227810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of the novel ultrasound contrast agent perflutren (definity) in patients with suboptimal baseline left ventricular echocardiographic images.
    Kitzman DW; Goldman ME; Gillam LD; Cohen JL; Aurigemma GP; Gottdiener JS
    Am J Cardiol; 2000 Sep; 86(6):669-74. PubMed ID: 10980221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Safety and efficiency of Echogen. Transthoracic echocardiography study].
    Espinola-Zavaleta N; Yánac-Chávez P; Vargas-Barrón J; Romero-Cárdenas A; Roldán-Gómez J
    Gac Med Mex; 2001; 137(3):203-8. PubMed ID: 11432089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opacification and border delineation improvement in patients with suboptimal endocardial border definition on routine echocardiography: results of a phase III trial of sonicated albumin microspheres.
    Crouse LJ; Kramer PH
    Clin Cardiol; 1991 Nov; 14(11 Suppl 5):V19-22. PubMed ID: 1764836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sonicated albumin in exercise echocardiography: technique and feasibility to enhance endocardial visualization.
    Yvorchuk KJ; Sochowski RA; Chan KL
    J Am Soc Echocardiogr; 1996; 9(4):462-9. PubMed ID: 8827629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differing susceptibility of echocardiographic contrast agents to adverse effects of biologic factors: multicenter, videodensitometric comparison of octafluoropropane-filled microspheres with air-filled microspheres for left ventricular opacification.
    Hausnerova E; Gottdiener JS; Gould JJ; Pezzullo JC; Callahan JD; Cohen JL; Bruns DE; Kuvelas MT; West HE; Dittrich HC
    J Am Soc Echocardiogr; 1999 Nov; 12(11):957-66. PubMed ID: 10552357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter evaluation of SonoVue for improved endocardial border delineation.
    Nanda NC; Wistran DC; Karlsberg RP; Hack TC; Smith WB; Foley DA; Picard MH; Cotter B
    Echocardiography; 2002 Jan; 19(1):27-36. PubMed ID: 11884252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. For left ventricular opacification and endocardial border definition: is it really important which contrast agent we use, or is it the imaging modality we choose?
    Dolan MS; El-Shafei A; Puri S; Tamirisa K; St Vrain J; Flanagan J; Havens E; Labovitz AJ
    Eur J Echocardiogr; 2001 Sep; 2(3):154-62. PubMed ID: 11882448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imagent improves endocardial border delineation, inter-reader agreement, and the accuracy of segmental wall motion assessment.
    Nanda NC; Kitzman DW; Dittrich HC; Hall G;
    Echocardiography; 2003 Feb; 20(2):151-61. PubMed ID: 12848680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of an intravenous perfluorocarbon contrast agent improves echocardiographic determination of left ventricular volumes and ejection fraction: comparison with cine magnetic resonance imaging.
    Hundley WG; Kizilbash AM; Afridi I; Franco F; Peshock RM; Grayburn PA
    J Am Coll Cardiol; 1998 Nov; 32(5):1426-32. PubMed ID: 9809958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sonicated serum albumin in contrast echocardiography: improved segmental wall motion depiction and implications for stress echocardiography.
    Crouse LJ
    Am J Cardiol; 1992 Jun; 69(20):42H-45H. PubMed ID: 1605120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-enhanced harmonic color Doppler for left ventricular opacification: improved endocardial border definition compared to tissue harmonic imaging and optimization of methodologyin patients with suboptimal echocardiograms.
    Chen L; Colonna P; Corda M; Cadeddu C; Montisci R; Caiati C; Meloni L; Iliceto S
    Echocardiography; 2001 Nov; 18(8):639-49. PubMed ID: 11801205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infusion versus bolus contrast echocardiography: a multicenter, open-label, crossover trial.
    Weissman NJ; Cohen MC; Hack TC; Gillam LD; Cohen JL; Kitzman DW
    Am Heart J; 2000 Mar; 139(3):399-404. PubMed ID: 10689253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocardial border delineation during dobutamine infusion using contrast echocardiography.
    Mathias W; Arruda AL; Andrade JL; Filho OC; Porter TR
    Echocardiography; 2002 Feb; 19(2):109-14. PubMed ID: 11926972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of a new intravenous echo contrast agent (BY 963) with Albunex for opacification of left ventricular cavity.
    Leischik R; Beller KD; Erbel R
    Basic Res Cardiol; 1996; 91(1):101-9. PubMed ID: 8660247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous albunex during dobutamine stress echocardiography: enhanced localization of left ventricular endocardial borders.
    Falcone RA; Marcovitz PA; Perez JE; Dittrich HC; Hopkins WE; Armstrong WF
    Am Heart J; 1995 Aug; 130(2):254-8. PubMed ID: 7631604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Improved left ventricular endocardial detection by a first generation contrast agent. Effect of dose].
    Vargas F; Hilbert G; Gruson D; Chene G; Journot V; Diebold B; Roudaut R
    Arch Mal Coeur Vaiss; 2000 Jan; 93(1):41-7. PubMed ID: 11227717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the technically limited echocardiographic study an endangered species? endocardial border definition with native tissue harmonic imaging and Optison contrast: a review of 200 cases.
    Malhotra V; Nwogu J; Bondmass MD; Bean M; Bieniarz T; Tertell M; Conliss M; Devries S
    J Am Soc Echocardiogr; 2000 Aug; 13(8):771-3. PubMed ID: 10936821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.